Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,932 | 368 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Supernus Pharmaceuticals, Inc. | $861.27 | 40 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $582.62 | 44 | $0 (2021) |
| ABBVIE INC. | $574.32 | 37 | $0 (2024) |
| PFIZER INC. | $436.30 | 41 | $0 (2023) |
| Novo Nordisk Inc | $418.37 | 25 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $279.63 | 16 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $210.22 | 12 | $0 (2024) |
| ITI, Inc. | $193.72 | 11 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $181.51 | 14 | $0 (2021) |
| Vanda Pharmaceuticals Inc. | $163.45 | 7 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,389 | 61 | Supernus Pharmaceuticals, Inc. ($367.49) |
| 2023 | $744.62 | 44 | ITI, Inc. ($139.83) |
| 2022 | $427.78 | 27 | Otsuka America Pharmaceutical, Inc. ($70.01) |
| 2021 | $632.05 | 36 | AbbVie Inc. ($165.89) |
| 2020 | $394.76 | 27 | Supernus Pharmaceuticals, Inc. ($153.04) |
| 2019 | $1,137 | 82 | Sunovion Pharmaceuticals Inc. ($243.32) |
| 2018 | $964.56 | 72 | Sunovion Pharmaceuticals Inc. ($270.43) |
| 2017 | $241.82 | 19 | Otsuka America Pharmaceutical, Inc. ($32.38) |
All Payment Transactions
368 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: PSYCHIATRY | ||||||
| 12/19/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: Central Nervous System | ||||||
| 12/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: Cardio-renal | ||||||
| 12/11/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: Central Nervous System | ||||||
| 12/09/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $25.38 | General |
| Category: PSYCHIATRY | ||||||
| 12/04/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $8.98 | General |
| Category: PSYCHIATRY | ||||||
| 12/03/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $24.81 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 12/03/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: RESPIRATORY | ||||||
| 11/27/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: PSYCHIATRY | ||||||
| 11/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.31 | General |
| Category: NEUROSCIENCE | ||||||
| 11/24/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $24.03 | General |
| Category: Neuropsychiatry | ||||||
| 11/21/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: PSYCHIATRY | ||||||
| 11/19/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: Central Nervous System | ||||||
| 11/14/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $21.31 | General |
| Category: Obesity | ||||||
| 11/11/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: Cardio-renal | ||||||
| 11/08/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $22.30 | General |
| Category: PSYCHIATRY | ||||||
| 11/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.55 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $12.97 | General |
| Category: PSYCHIATRY | ||||||
| 10/31/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $23.64 | General |
| Category: PSYCHIATRY | ||||||
| 10/31/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: RESPIRATORY | ||||||
| 10/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.79 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $25.70 | General |
| Category: Oncology | ||||||
| 10/11/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $27.66 | General |
| 10/10/2024 | Novo Nordisk Inc | Saxenda (Drug), Wegovy | Food and Beverage | In-kind items and services | $24.48 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 114 | 228 | $3,831 | $1,232 |
| 2022 | 2 | 76 | 92 | $1,652 | $563.70 |
| 2021 | 3 | 63 | 98 | $2,692 | $748.95 |
| 2020 | 5 | 118 | 160 | $5,138 | $1,414 |
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 83036 | Hemoglobin a1c level | Office | 2023 | 47 | 82 | $2,106 | $780.64 | 37.1% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 52 | 129 | $1,478 | $414.09 | 28.0% |
| 81003 | Automated urinalysis test | Office | 2023 | 15 | 17 | $246.84 | $37.40 | 15.2% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 36 | 42 | $1,079 | $402.17 | 37.3% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2022 | 40 | 50 | $573.00 | $161.53 | 28.2% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 24 | 37 | $950.16 | $359.27 | 37.8% |
| 82274 | Stool analysis for blood, by fecal hemoglobin determination by immunoassay | Office | 2021 | 13 | 15 | $1,215 | $238.80 | 19.7% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2021 | 26 | 46 | $527.16 | $150.88 | 28.6% |
| G0180 | Physician certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implem | Office | 2020 | 12 | 12 | $1,955 | $450.31 | 23.0% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 31 | 41 | $1,053 | $395.07 | 37.5% |
| 82274 | Stool analysis for blood | Office | 2020 | 16 | 18 | $1,013 | $285.92 | 28.2% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2020 | 38 | 64 | $733.44 | $207.61 | 28.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 21 | 25 | $383.25 | $74.88 | 19.5% |
About Dr. Kathy Rosema, DO
Dr. Kathy Rosema, DO is a Family Medicine healthcare provider based in Shelby, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1689628927.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kathy Rosema, DO has received a total of $5,932 in payments from pharmaceutical and medical device companies, with $1,389 received in 2024. These payments were reported across 368 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($5,932).
As a Medicare-enrolled provider, Rosema has provided services to 371 Medicare beneficiaries, totaling 578 services with total Medicare billing of $3,959. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Shelby, MI
- Active Since 05/20/2006
- Last Updated 05/19/2017
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1689628927
Products in Payments
- LATUDA (Drug) $529.77
- TROKENDI XR (Drug) $493.78
- CAPLYTA (Drug) $403.94
- VRAYLAR (Drug) $387.90
- REXULTI (Drug) $374.21
- Qelbree (Drug) $367.49
- CHANTIX (Drug) $175.50
- UBRELVY (Drug) $157.36
- ELIQUIS (Drug) $129.29
- Kerendia (Drug) $118.14
- Ozempic (Drug) $113.93
- FARXIGA (Drug) $105.97
- BEXSERO (Biological) $94.12
- Tresiba (Drug) $85.90
- Austedo XR (Drug) $85.73
- VYVANSE (Drug) $85.60
- HETLIOZ (Drug) $84.50
- Rybelsus (Drug) $76.76
- QULIPTA (Drug) $76.51
- JARDIANCE (Drug) $70.66
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Shelby
Stephen Jones, Md, MD
Family Medicine — Payments: $33,877
Mr. Alan Jubane, Md, MD
Family Medicine — Payments: $12,615
Surendra Pal Sidhu, Md, MD
Family Medicine — Payments: $12,476
Christian Martin, Md, MD
Family Medicine — Payments: $8,277
Dr. Kenneth Cloninger, Md, MD
Family Medicine — Payments: $5,149
Lynda Lachance, Md, MD
Family Medicine — Payments: $3,885